| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | fosfomycin trometamol (Monuril®) |
| Formulation | 3g granules for oral solution |
| Reference number | 3346 |
| Indication | Treatment of acute lower uncomplicated urinary tract infections, caused by pathogens sensitive to fosfomycin in adult and adolescent females; prophylaxis in diagnostic and surgical transurethral procedures. Consideration should be given to national guidance on the appropriate use of antibacterial agents |
| Company | Zambon SpA |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/12/2016 |